<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药魔方Pro | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-29T23:17:14+08:00</updated>
  <subtitle>聚焦生物医药前沿，洞察研发投资风向</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>Science：解决耐药难题，这款来自海洋的抗真菌药有何奇效？</title>
    <updated>2020-12-29T20:58:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-29:/s/xM27HynhPUQFU_i5609VTQ</id>
    <link href="https://mp.weixin.qq.com/s/xM27HynhPUQFU_i5609VTQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>乳腺癌治疗新靶点——LINC01271 | Nature子刊</title>
    <updated>2020-12-28T21:00:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/r09erh0cFfwYl-iBRNKloQ</id>
    <link href="https://mp.weixin.qq.com/s/r09erh0cFfwYl-iBRNKloQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>PROTAC之后，分子胶成热门！这家新锐公司A轮融资1.09亿美元，有何独特背景？</title>
    <updated>2020-12-27T21:04:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-27:/s/Mu_ibYyMXx57POLzhFXDSQ</id>
    <link href="https://mp.weixin.qq.com/s/Mu_ibYyMXx57POLzhFXDSQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>豪斥10亿美元！默沙东锁定TRACTr技术，开发下一代T细胞疗法</title>
    <updated>2020-12-26T21:03:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/BL_E2KiSfgDLHzDXfM941w</id>
    <link href="https://mp.weixin.qq.com/s/BL_E2KiSfgDLHzDXfM941w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Nature里程碑：双管齐下的抗生素——IspH抑制剂</title>
    <updated>2020-12-25T20:58:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/4NTqChI4CzIqweR63ULPmg</id>
    <link href="https://mp.weixin.qq.com/s/4NTqChI4CzIqweR63ULPmg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Nature最新报告：外泌体疗法，迈向临床</title>
    <updated>2020-12-24T20:59:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/mZgRzcbAfmdtTwTG55v3zQ</id>
    <link href="https://mp.weixin.qq.com/s/mZgRzcbAfmdtTwTG55v3zQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>姜宝红点评 | Nature：心血管疾病诊断和治疗新靶点——ALDH4A1</title>
    <updated>2020-12-23T20:59:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/Ud_9EhwLp7vbZxuveZmNCQ</id>
    <link href="https://mp.weixin.qq.com/s/Ud_9EhwLp7vbZxuveZmNCQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>抗癌靶点XPO1「图鉴」</title>
    <updated>2020-12-22T20:58:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/1isEKx3qcPjL1inedk-HOA</id>
    <link href="https://mp.weixin.qq.com/s/1isEKx3qcPjL1inedk-HOA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Nature：首个Tau抗体临床试验失败，阿尔茨海默症Tau药物还有哪些希望？</title>
    <updated>2020-12-21T20:58:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/lzoCUobFpgR1HEd6JBEu8g</id>
    <link href="https://mp.weixin.qq.com/s/lzoCUobFpgR1HEd6JBEu8g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>诺华、默沙东之后，GSK又下8.15亿美元大单！这家癌症免疫疗法公司有何重磅产品？</title>
    <updated>2020-12-20T20:59:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/mUQuWNw2OmhWzT0SBeVGoQ</id>
    <link href="https://mp.weixin.qq.com/s/mUQuWNw2OmhWzT0SBeVGoQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>